Compare CSTL & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | PRSU |
|---|---|---|
| Founded | 2007 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 940.8M | 946.6M |
| IPO Year | 2019 | N/A |
| Metric | CSTL | PRSU |
|---|---|---|
| Price | $29.72 | $34.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $46.67 | $31.67 |
| AVG Volume (30 Days) | ★ 390.1K | 186.3K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $344,229,000.00 | N/A |
| Revenue This Year | $3.15 | $26.24 |
| Revenue Next Year | N/A | $6.25 |
| P/E Ratio | ★ N/A | $3.45 |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $14.59 | $26.90 |
| 52 Week High | $44.28 | $39.93 |
| Indicator | CSTL | PRSU |
|---|---|---|
| Relative Strength Index (RSI) | 33.66 | 40.49 |
| Support Level | $21.77 | $34.17 |
| Resistance Level | $34.97 | $37.75 |
| Average True Range (ATR) | 1.71 | 1.25 |
| MACD | -0.10 | -0.29 |
| Stochastic Oscillator | 31.72 | 36.20 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.